Critical Outcome Technologies Appoints Experienced Industry Executive as New President
June 15, 2016 09:15 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON--(Marketwired - June 15, 2016) - Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Company"), a clinical stage biopharmaceutical company advancing a...
Critical Outcome Announces No Material Change
June 08, 2016 19:05 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON--(Marketwired - June 08, 2016) - Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Company") is issuing this press release in response to a request by...
Critical Outcome Activates Second Clinical Trial Site for Its COTI-2 Gynecological Cancer Study
June 06, 2016 08:30 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON--(Marketwired - June 06, 2016) - Critical Outcome Technologies Inc. (TSX VENTURE: COT)(OTCQB: COTQF) ("COTI" or the "Company") announced today the opening on June 3, 2016, of a second...
Critical Outcome Technologies Receives $1.6M From Warrant Exercises
June 03, 2016 09:07 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON--(Marketwired - June 03, 2016) -
Critical Outcome Technologies Inc.
(TSX VENTURE: COT)
(OTCQB: COTQF)
("COTI" or the "Company") announced today that all the common...
Critical Outcome to Present at International Li-Fraumeni Syndrome Conference and at BIO International Convention
June 01, 2016 08:30 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON--(Marketwired - June 01, 2016) -
Critical Outcome Technologies Inc.
(TSX VENTURE: COT)
(OTCQB: COTQF)
("COTI" or the "Company") announced today that the Company has...
Critical Outcome Receives Additional Patent Protection for Potential Transformational P53 Cancer Treatment
May 24, 2016 08:30 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON--(Marketwired - May 24, 2016) -
Critical Outcome Technologies Inc.
(TSX VENTURE: COT)
(OTCQB: COTQF)
("COTI" or the "Company") announced today that it has recently...
Critical Outcome Technologies Announces Additional Funding Through Warrant Exercises
May 02, 2016 08:00 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON--(Marketwired - May 02, 2016) -
Critical Outcome Technologies Inc.
(TSX VENTURE: COT)
(OTCQB: COTQF)
("COTI" or the "Company") announced today that all the common...
Critical Outcome Technologies Augments Advisory Board Drug Development Experience
April 27, 2016 08:00 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON--(Marketwired - April 27, 2016) -
Critical Outcome Technologies Inc.
(TSX VENTURE: COT)
(OTCQB: COTQF)
("COTI" or the "Company") announced today the addition of Dr....
Critical Outcome Commences Treatment of Second Cohort in Phase 1 Study of COTI-2 in Gynecologic Cancers
April 19, 2016 08:30 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON--(Marketwired - April 19, 2016) -
Critical Outcome Technologies Inc. ("COTI" or the "Company")
(TSX VENTURE: COT)
(OTCQB: COTQF), announced today that the Company...
Critical Outcome Technologies Completes Private Placement With a Successful U.S. Life Science Investor
March 30, 2016 08:15 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON--(Marketwired - March 30, 2016) -
This news release is intended for distribution in Canada only and is not intended for distribution to United States newswire services or...